237 related articles for article (PubMed ID: 30614347)
1. Testosterone, testosterone therapy and prostate cancer.
Yassin A; AlRumaihi K; Alzubaidi R; Alkadhi S; Al Ansari A
Aging Male; 2019 Dec; 22(4):219-227. PubMed ID: 30614347
[TBL] [Abstract][Full Text] [Related]
2. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
Morgentaler A; Traish AM
Eur Urol; 2009 Feb; 55(2):310-20. PubMed ID: 18838208
[TBL] [Abstract][Full Text] [Related]
3. Effects of androgen deficiency and replacement on prostate zonal volumes.
Jin B; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.
Golla V; Kaplan AL
Curr Urol Rep; 2017 Jul; 18(7):49. PubMed ID: 28589395
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer risk in testosterone-treated men.
Raynaud JP
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
[TBL] [Abstract][Full Text] [Related]
6. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
Mostaghel EA; Page ST; Lin DW; Fazli L; Coleman IM; True LD; Knudsen B; Hess DL; Nelson CC; Matsumoto AM; Bremner WJ; Gleave ME; Nelson PS
Cancer Res; 2007 May; 67(10):5033-41. PubMed ID: 17510436
[TBL] [Abstract][Full Text] [Related]
7. Testosterone Therapy in Men With Prostate Cancer.
Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
[TBL] [Abstract][Full Text] [Related]
8. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
9. A new era of testosterone and prostate cancer: from physiology to clinical implications.
Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Therapy Among Prostate Cancer Survivors.
Nguyen TM; Pastuszak AW
Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
13. Testosterone deficiency syndrome: treatment and cancer risk.
Raynaud JP
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):96-105. PubMed ID: 19429438
[TBL] [Abstract][Full Text] [Related]
14. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
Kaufman J
Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
[TBL] [Abstract][Full Text] [Related]
15. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
[TBL] [Abstract][Full Text] [Related]
16. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
17. [Prostate carcinoma and testosterone: risks and controversies].
Rhoden EL; Averbeck MA
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
[TBL] [Abstract][Full Text] [Related]
18. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
Algarté-Génin M; Cussenot O; Costa P
Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
[TBL] [Abstract][Full Text] [Related]
19. Testosterone Therapy and Prostate Cancer.
Davidson E; Morgentaler A
Urol Clin North Am; 2016 May; 43(2):209-16. PubMed ID: 27132578
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
